Short Interest in The Oncology Institute, Inc. (NASDAQ:TOIIW) Decreases By 45.2%

The Oncology Institute, Inc. (NASDAQ:TOIIW) was the target of a significant decrease in short interest in January. As of January 15th, there was short interest totalling 1,700 shares, a decrease of 45.2% from the December 31st total of 3,100 shares. Based on an average daily volume of 24,200 shares, the short-interest ratio is currently 0.1 days.

Oncology Institute Stock Performance

Shares of TOIIW stock traded down $0.00 on Wednesday, hitting $0.04. The company had a trading volume of 26,633 shares, compared to its average volume of 42,146. Oncology Institute has a twelve month low of $0.01 and a twelve month high of $0.37. The company has a 50-day moving average price of $0.02 and a 200-day moving average price of $0.02.

About Oncology Institute

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.